These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17562623)

  • 21. Successful unrelated cord blood transplantation for Epstein-Barr virus-associated lymphoproliferative disease with hemophagocytic syndrome.
    Toubo T; Suga N; Ohga S; Nomura A; Onoe Y; Takada H; Hara T
    Int J Hematol; 2004 Dec; 80(5):458-62. PubMed ID: 15646660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease.
    Ito Y; Suzuki M; Kawada J; Kimura H
    J Infect Chemother; 2016 Apr; 22(4):268-71. PubMed ID: 26712582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fatal exacerbations of chronic active Epstein-Barr virus infection subsequent to cytotoxic chemotherapy].
    Suma S; Kurita N; Baba N; Ishitsuka K; Sukegawa S; Makishima K; Kiyoki Y; Maruyama Y; Kato T; Yokoyama Y; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2019; 60(4):286-290. PubMed ID: 31068557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How we treat chronic active Epstein-Barr virus infection.
    Sawada A; Inoue M; Kawa K
    Int J Hematol; 2017 Apr; 105(4):406-418. PubMed ID: 28210942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival.
    Auger S; Orsini M; Céballos P; Fegueux N; Kanouni T; Caumes B; Klein B; Villalba M; Rossi JF
    Eur J Haematol; 2014; 92(5):421-8. PubMed ID: 24400833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
    Okamura T; Hatsukawa Y; Arai H; Inoue M; Kawa K
    Lancet; 2000 Jul; 356(9225):223-4. PubMed ID: 10963205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CD34+ progenitor cell transplantation from HLA-mismatched donors to two patients with chronic active Epstein-Barr virus infection].
    Yasui M; Okamura T; Sakata N; Inoue M; Yagi K; Yoshimoto T; Mabuchi O; Sano M; Kawa K
    Rinsho Ketsueki; 2001 Nov; 42(11):1111-6. PubMed ID: 11808080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.
    Coppoletta S; Tedone E; Galano B; Soracco M; Raiola AM; Lamparelli T; Gualandi F; Bregante S; Ibatici A; di Grazia C; Dominietto A; Varaldo R; Bruno B; Frassoni F; Van Lint MT; Bacigalupo A
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):901-7. PubMed ID: 20950702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
    Taketani T; Kikuchi A; Inatomi J; Hanada R; Kawaguchi H; Ida K; Oh-Ishi T; Arai T; Kishimoto H; Yamamoto K
    Bone Marrow Transplant; 2002 Mar; 29(6):531-3. PubMed ID: 11960276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.
    Ebihara Y; Manabe A; Tanaka R; Yoshimasu T; Ishikawa K; Iseki T; Hayakawa J; Maeda M; Asano S; Tsuji K
    Bone Marrow Transplant; 2003 Jun; 31(12):1169-71. PubMed ID: 12796798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Virus-specific cytotoxic T cells in chronic active Epstein-Barr virus infection].
    Shibayama H; Imadome KI; Onozawa E; Tsuzura A; Miura O; Koyama T; Arai A
    Rinsho Ketsueki; 2017; 58(6):583-588. PubMed ID: 28679986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A Case of Severe Chronic Active Epstein-Barr Virus Infection with Aplastic Anemia and Hepatitis].
    Lee JI; Lee SW; Han NI; Ro SM; Noh YS; Jang JW; Bae SH; Choi JY; Yoon SK
    Korean J Gastroenterol; 2016 Jan; 67(1):39-43. PubMed ID: 26809631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrence of chronic active Epstein-Barr virus infection presenting with myelopathy after umbilical cord blood transplantation].
    Watanabe S; Okada M; Tokugawa T; Sawada A; Ogawa H; Yoshikawa H
    Rinsho Shinkeigaku; 2014; 54(10):809-13. PubMed ID: 25342015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratory characteristics of chronic active Epstein-Barr virus infection in children].
    Mao JQ; Yang SL; Song H; Zhao FY; Xu XJ; Gu ME; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1081-5. PubMed ID: 25406547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
    Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr Virus-positive T-cell Lymphoproliferative Disease Following Umbilical Cord Blood Transplantation for Acute Myeloid Leukemia.
    Yui S; Yamaguchi H; Imadome K; Arai A; Takahashi M; Ohashi R; Tamai H; Moriya K; Nakayama K; Shimizu A; Inokuchi K
    J Nippon Med Sch; 2016; 83(1):35-42. PubMed ID: 26960588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.